Weight management as a primary treatment goal for type 2 diabetes: time to reframe the conversation <br><br>Eli Lilly and Company | <br>Friday
Ildiko Lingvay (USA) 23.09.2022 08:15 – 08:25 VIRTUAL ONLY: Cori Hall
Is HFpEF hiding in your practice? An expert debate on the emerging role of diabetologists<br> <br> PACE-CME funded by an unrestricted educational grant provided by AstraZeneca | <br>Friday
Chair: Silvio Inzucchi (USA) 08:00 – 08:05 Introduction All faculty 08:05 – 08:10 Update on new developments of HFpEF and diabetes Silvio Inzucchi (USA) 08:10 – 08:15 HFpEF and Diabetes: What are the clinical challenges? Pardeep Jhund (UK) 08:15 – 08:30 How does new evidence impact the need for identification and management of patients with […]
CGM in the ADA / EASD Consensus Report and Eversense E3 CGM in clinical practice. <br> <br>Ascensia Diabetes Care | <br>Thursday
18:30 – 18:50 CGM in ADA / EASD Consensus report.Use of Eversense in diabetes treatment. Tomasz Klupa (POL) 18:50 – 19:10 Eversense CGM System in clinical practice. Sergio Di Molfetta (ITA) 19:10 – 19:30 The new evolution of Eversense technology. Francine Kaufmann (USA) 22.09.2022 18:30 – 19:30 Yalow Hall
How Smart Insulin Pens are Transforming MDI therapy: Perspectives from our R&D Clinical Expert<br><br>Medtronic International Trading Sàrl | <br>Tuesday
Chair: Anna-Rea Laubscher (CHE) 15:45 – 16:15 How Smart Insulin Pens are Transforming MDI therapy: Perspectives from our R&D Clinical Expert Madison Smith (USA) 20.09.2022 15:45 – 16:15 Networking Hub
Successful initiation of the MiniMed 780G system<br><br><br>Medtronic International Trading Sàrl | <br>Wednesday
11:45 – 11:55 Introducing the MiniMed 780G system Ohad Cohen (ISR) 11:55 – 12:15 Succesful initiation of the MiniMed 780G system: practical case Goran Petrovski (QAT) Chair: Ohad Cohen (ISR) 21.09.2022 11:45 – 12:15 Networking Hub
Weight management as a primary treatment goal for type 2 diabetes: time to reframe the conversation <br><br>Eli Lilly and Company | <br>Wednesday
Ildiko Lingvay (USA) 21.09.2022 08:15 – 08:25 VIRTUAL ONLY: Cori Hall
Coming soon<br><br>Sanofi | <br>Thursday
Agenda coming soon… 22.09.2022 13:00 – 13:30 Networking Hub
Understanding the importance of individualizing glycemic targets – An expert debate on individualized target ranges and percentages <br><br>Abbott | <br>Wednesday
16:00 – 16:15 How to individualize Time in Range goals of my patients 16:15 – 16:30 How to individualize my patients’ percentage goals of their personal target ranges 21.09.2022 16:00 – 16:30 Networking Hub
Time to move beyond A1c with Time in Range – An expert debate on the next-level standard of diabetes care <br><br>Abbott | <br>Wednesday
13:00 – 13:15 Key challenges with the Gold Standard A1c in diabetes management in the daily practice 13:15 – 13:30 How can TIR empower my diabetes team in the daily practice? 21.09.2022 13:00 – 13:30 Networking Hub
Podcast | Boehringer Ingelheim and Eli Lilly and Company
Coming soon…
